GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Other Cash Receipts from Operating Activities

Radiopharm Theranostics (ASX:RAD) Other Cash Receipts from Operating Activities : A$5.11 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Other Cash Receipts from Operating Activities?

Radiopharm Theranostics's Other Cash Receipts from Operating Activities for the six months ended in Dec. 2023 was A$4.85 Mil.

Radiopharm Theranostics's Other Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 was A$5.11 Mil.


Radiopharm Theranostics Other Cash Receipts from Operating Activities Historical Data

The historical data trend for Radiopharm Theranostics's Other Cash Receipts from Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Other Cash Receipts from Operating Activities Chart

Radiopharm Theranostics Annual Data
Trend Jun22 Jun23 Jun24
Other Cash Receipts from Operating Activities
- 1.56 4.85

Radiopharm Theranostics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Cash Receipts from Operating Activities Get a 7-Day Free Trial - - 1.56 4.85 0.26

Radiopharm Theranostics Other Cash Receipts from Operating Activities Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Other Cash Receipts from Operating Activities represents cash flow received from other operating activities in the direct cash flow method.

GuruFocus lists following items in "Cash Receipts from Operating Activities" section for non-financial companies:
Receipts from Customers
Receipts from Government Grants
Other Cash Receipts from Operating Activities

Other Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$5.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Radiopharm Theranostics Other Cash Receipts from Operating Activities Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Other Cash Receipts from Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


Radiopharm Theranostics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Other Cash Receipts from Operating Activities
Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.

Radiopharm Theranostics Headlines

No Headlines